Literature DB >> 7930588

Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production.

A Kavelaars1, D Broeke, F Jeurissen, J Kardux, A Meijer, R Franklin, E W Gelfand, C J Heijnen.   

Abstract

Substance P (SP) is a tachykinin involved in the regulation of inflammatory processes. Tachykinins bind to three subtypes of neurokinin (NK) receptors. However, recently we demonstrated that monocytes express a SP binding site that is not one of the known NK receptors. Activation of this SP receptor leads to the stimulation of MAP kinase in monocytes. In the present paper we show that this novel SP binding site is coupled to a GTP binding protein of the Gi alpha 1/2 subclass. Triggering of the SP receptor leads to a rapid rise in cytosolic calcium. In a more sustained way, SP stimulates phospholipase D (PLD) activity in human monocytes. The effects of SP on calcium, PLD, and MAP kinase activity can be blocked by pretreatment of the cells with pertussis toxin, which is in agreement with receptor coupling to Gi. At a functional level, stimulation of the non-NK SP receptor on monocytes results in the induction of IL-6 production. We show here that the order of potency for activation of monocytes by various ligands is directly related to the Ki for displacement of labeled SP by these ligands. Therefore, our data strongly suggest that the effects of SP are mediated via the novel SP receptor we recently described.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930588

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

2.  Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.

Authors:  T Goode; J O'Connell; W Z Ho; G C O'Sullivan; J K Collins; S D Douglas; F Shanahan
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 3.  The peritoneum--an important factor for pathogenesis and pain generation in endometriosis.

Authors:  Maria-Luisa Barcena de Arellano; Sylvia Mechsner
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

4.  Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).

Authors:  Irene Chernova; Jian-Ping Lai; Haiying Li; Lynnae Schwartz; Florin Tuluc; Helen M Korchak; Steven D Douglas; Laurie E Kilpatrick
Journal:  J Leukoc Biol       Date:  2008-10-03       Impact factor: 4.962

Review 5.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

Review 6.  Biological and Pharmacological Aspects of the NK1-Receptor.

Authors:  Susana Garcia-Recio; Pedro Gascón
Journal:  Biomed Res Int       Date:  2015-09-03       Impact factor: 3.411

7.  The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation.

Authors:  Susana Garcia-Recio; Eva M Pastor-Arroyo; Mercedes Marín-Aguilera; Vanessa Almendro; Pedro Gascón
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 8.  The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.

Authors:  Annabel J Sorby-Adams; Amanda M Marcoionni; Eden R Dempsey; Joshua A Woenig; Renée J Turner
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

9.  Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.

Authors:  Kate Marie Lewis; Renée Jade Turner; Robert Vink
Journal:  Int J Inflam       Date:  2013-05-29

10.  The role of substance p in ischaemic brain injury.

Authors:  Renée J Turner; Robert Vink
Journal:  Brain Sci       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.